Please use this identifier to cite or link to this item:
Title: In vivo model for dyslipidemia with diabetes mellitus in hamster*
Authors: Bhatia, Gitika
Rizvi, Farhan
Saxena, Rashmi
Puri, Anju
Khanna, A K
Chander, Ramesh
Wulff, E M
Rastogi, A K
Keywords: Diabetes;Dyslipidemia;Hyperglycemia;Lipid lowering drugs;In vivo model
Issue Date: Dec-2003
Publisher: NISCAIR-CSIR, India
Abstract: Due to similarities in lipid metabolism to those in humans, hamster is considered as a good model for the study of regulatory mechanisms of plasma lipoproteins in response to cholesterol or fatty acid-enriched diet. This model of hyperlipidemia has been modified to produce dyslipidedmia with diabetes complexities by feeding with high fat diet added with 9% (w/w) fructose. Feeding this diet to hamster for 10 days markedly increases plasma levels of triglyceride, cholesterol,  fatty acids followed by a significant increase in glycerol, β lipoproteins, high density lipoprotein, glucose and glycosylated proteins. This model is being used for research and development of lipid lowering drugs with hypoglycemic activity in collaboration with Novo Nordisk, Denmark. The modified high fat diet formulation has now been prepared (Research diet D.99122211) and supplied by Research Diets Inc, Burnswick USA.
Page(s): 1456-1459
ISSN: 0975-1009 (Online); 0019-5189 (Print)
Appears in Collections:IJEB Vol.41(12) [December 2003]

Files in This Item:
File Description SizeFormat 
IJEB 41(12) 1456-1459.pdf912.49 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.